Viruses and lymphoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pathology (Sydney)

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/003130200500368303PMID 16373225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor immunity against adult T‐cell leukemia

  2005cited by this paper
• Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.

  2005cited by this paper
• Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.

  2005cited by this paper
• Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.

  2005cited by this paper
• Cellular Immunity to Epstein‐Barr Virus in Liver Transplant Recipients Treated with Rituximab for Post‐Transplant Lymphoproliferative Disease

  2005cited by this paper
• Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas.

  2005cited by this paper
• The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care

  2005cited by this paper
• Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy

  2005cited by this paper
• Treatment of EBV‐Related Post‐Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV‐Specific T Cells

  2005cited by this paper
• Gastrointestinal lymphoma: where morphology meets molecular biology

  2005cited by this paper
• Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies

  2005cited by this paper
• Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas

  2005cited by this paper
• Epstein–Barr virus‐associated Hodgkin's lymphoma

  2004cited by this paper
• Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

  2004cited by this paper
• Literature abstracts

  2004influential reference
• Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

  2004cited by this paper
• B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review

  2004cited by this paper
• Lentiviral Vectors

  2004cited by this paper
• Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease

  2004cited by this paper
• AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART.

  2004cited by this paper
• Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas

  2004cited by this paper
• Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.

  2004cited by this paper
• Epstein–Barr virus: 40 years on

  2004influential reference
• Viruses and tumours--an update.

  2004cited by this paper
• CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1

  2004cited by this paper
• Establishment and Characterization of a Bank of Cytotoxic T Lymphocytes for Immunotherapy of Epstein-Barr Virus-Associated Diseases

  2004cited by this paper
• Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

  2004cited by this paper
• Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine

  2004influential reference
• Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

  2004cited by this paper
• Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

  2004cited by this paper
• Adult Burkitt leukemia and lymphoma.

  2004cited by this paper
• Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.

  2003cited by this paper
• Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

  2003cited by this paper
• Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.

  2003cited by this paper
• A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

  2003cited by this paper
• A single-centre experience of post-renal transplant lymphoproliferative disorder

  2003cited by this paper
• Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues

  2003cited by this paper
• B cells under influence: transformation of B cells by Epstein–Barr virus

  2003cited by this paper
• BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.

  2003cited by this paper
• Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.

  2003cited by this paper
• Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1

  2003cited by this paper
• Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.

  2003cited by this paper
• Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.

  2003cited by this paper
• Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines

  2003cited by this paper
• Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

  2003influential reference
• Low dose interferon-α therapy for HIV-associated multicentric Castleman's disease

  2003cited by this paper
• Novel therapies based on mechanisms of HIV-1 cell entry.

  2003cited by this paper
• Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development

  2003cited by this paper
• Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

  2003cited by this paper
• Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.

  2003cited by this paper
• Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2

  2002cited by this paper
• Hodgkin's lymphoma: the pathologist's viewpoint.

  2002cited by this paper
• Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma.

  2002cited by this paper
• Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia.

  2002cited by this paper
• Lentiviral Vectors

  2002cited by this paper
• Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

  2002cited by this paper
• High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

  2002cited by this paper
• Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

  2002cited by this paper
• Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

  2002cited by this paper
• Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.

  2002cited by this paper
• Prevention and treatment of epstein–barr virus‐associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

  2002cited by this paper
• The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

  2002cited by this paper
• Hodgkin's disease in the elderly: a population‐based study

  2002cited by this paper
• Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity

  2002cited by this paper
• Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.

  2002influential reference
• Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

  2001cited by this paper
• Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

  2001influential reference
• Pathology and genetics: Tumours of haematopoietic and lymphoid tissues

  2001cited by this paper
• Long‐lasting complete remission of hepatitis C virus (HCV) infection and HCV‐associated immunocytoma with alpha‐interferon treatment

  2001cited by this paper
• REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1

  2001cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

  2001cited by this paper
• Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins.

  2001influential reference
• Epstein–Barr virus and survival after Hodgkin disease in a population‐based series of women

  2001cited by this paper
• Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France

  2001cited by this paper
• Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

  2001cited by this paper
• Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.

  2001cited by this paper
• Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition*

  2001cited by this paper
• Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

  2000cited by this paper
• Ly-1b cells and Castleman disease.

  2000cited by this paper
• Hepatitis C virus infection in patients with non-Hodgkin lymphoma in Thailand.

  2000cited by this paper
• Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.

  2000cited by this paper
• HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

  2000cited by this paper
• Cirrhosis of the liver in long-term marrow transplant survivors.

  1999cited by this paper
• Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells

  1999cited by this paper
• Detection of a Hodgkin/Reed‐Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease

  1999cited by this paper
• Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

  1999influential reference
• Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

  1999cited by this paper
• Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas

  1999cited by this paper
• Lymphoma in Patients with Rheumatoid Arthritis

  1999cited by this paper
• Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population.

  1999cited by this paper
• Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata

  1999cited by this paper
• Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

  1999influential reference
• Detection of Epstein‐Barr virus (EBV) genomes in the serum of patients with EBV‐associated Hodgkin's disease

  1999cited by this paper
• Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

  1999cited by this paper
• The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

  1999cited by this paper

• Extranodal lymphoma: pathogenesis, diagnosis and treatment

  2023cites this paper
• HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.

  2015cites this paper
• An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review

  2015cites this paper
• Présentée pour obtenir le grade DE DIPLÔME DE MAGISTÈRE EN AGRONOMIE Option : NUTRITION

  2011cites this paper
• Non Hodgkin's lymphoma with cutaneous involvement in AIDS patients: report of five cases and review of the literature.

  2010cites this paper
• Non Hodgkin ’ s lymphoma with cutaneous involvement in

  2010cites this paper
• Delayed exposure to infections and childhood lymphomas: a case–control study

  2009cites this paper
• Lymphoid Malignancies of Non-precursor Cells

  2008cites this paper
• Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition.

  2008cites this paper
• Invaginación ileocecal como forma de presentación de linfoma no Hodgkin en un paciente con SIDA

  2008cites this paper
• Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma

  2008cites this paper
• Lymphoma after living donor kidney transplantation: an Iranian multicenter experience

  2008cites this paper
• Oral cavity lymphoma as secondary AIDS-defining neoplasm in a patient on HAART with immune reconstitution.

  2007cites this paper
• Clinical perspectives in lymphoma

  2007cites this paper
• Burkitt's lymphoma of the duodenum in a patient with AIDS.

  2007cites this paper
• Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression

  2006cites this paper
• CHAPTER 16 Cancers in the Tropics

  2005cites this paper
• Lymphoproliferative disorders.

  2005cites this paper
• Simian Virus 40 Infection of Humans

  2003cites this paper
• MINIREVIEW Simian Virus 40 Infection of Humans

  2003cites this paper